Randomized Study Comparing Periodic Acceleration Versus Static Position in Cerebrovascular Stroke Patients

Fundacion Rioja Salud

Status: Withdrawn

Conditions: Cerebrovascular Stroke

Treatments: Device: Exer-Rest® TL

Study type: Interventional

Funder types: Other

Identifiers

NCT02038998

CIBIR002

Details and patient eligibility

About

Stroke is one of the leading causes of death and disability worldwide. More than 85% of strokes are due to blood vessel occlusion resulting in partial destruction of the brain parenchyma. Current protocols try to re-establish blood circulation as soon as possible through chemical and/or mechanical interventions but new strategies are needed.

Periodic acceleration (pGz) is a non-invasive method consisting in the application of a rocking movement to the patient that ultimately will induce the release of beneficial chemicals from the vascular endothelium (the cells lining the inside of the blood vessels). Application of pGz in an animal model of stroke resulted in a dramatic reduction of associated brain damage.

This trial will investigate whether stroke patients exposed to pGz experiment significantly higher recovery than patients that remained static during their treatment.

Full description

Periodic acceleration (pGz) is a non-invasive method consisting in the application of a rocking movement to the patient that ultimately will induce the release of beneficial chemicals from the vascular endothelium (the cells lining the inside of the blood vessels). Application of pGz in an animal model of stroke resulted in a dramatic reduction of associated brain damage.

This trial will investigate whether stroke patients exposed to pGz experiment significantly higher recovery than patients that remained static during their treatment.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A signed informed consent form must be obtained prior to recruitment
• Patients with symptoms of acute ischemic stroke
• Less than 12 hours from initiation of the stroke
• Age: 18 years or older
• Capable of following the protocol

Exclusion criteria

• Pregnant or lactating women, and women that do not follow a contraceptive plan and may become pregnant
• Less than 18 years of age
• More than 12 hours from the initiation of the stroke or when the initiation time is unknown.
• Hemorrhagic stroke
• Candidates to receive thrombolytic treatment
• Spine traumatism or other conditions that may be aggravated by pGz
• Patients that cannot be properly followed because of phycological, social, familiar, or geographical reasons.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

0 participants in 3 patient groups

Static group

Sham Comparator group

Description:

Control group. They will receive the standard care provided by the protocols of the ictus unit. They will lay on the Exer-Rest® TL device but the acceleration will NOT be connected.

Treatment:

Device: Exer-Rest® TL

Single pGz intervention

Experimental group

Description:

In addition to the standard care established in the ictus unit, these patients will receive a single exposure to pGz on the Exer-Rest® TL, for 3 hours, during the first day of their stay in the hospital.

Treatment:

Device: Exer-Rest® TL

Multiple pGz interventions

Experimental group

Description:

In addition to the standard care, these patients will be exposed to 45 minutes of pGz, on the Exer-Rest® TL, every day during their first week in the Hospital.

Treatment:

Device: Exer-Rest® TL